Observational cohort study focused on treatment continuity of patients (pts) treated with XELOX plus bevacizumab (BV) for previously untreated metastatic colorectal cancer (mCRC).
Masahito Kotaka
Honoraria - Chugai Pharma
Husao Ikeda
No relevant relationships to disclose
Taro Ikumoto
No relevant relationships to disclose
Masaki Tsuzie
No relevant relationships to disclose
Shinichi Yoshioka
No relevant relationships to disclose
Yoshihiko Nakamoto
No relevant relationships to disclose
Takaaki Ishii
No relevant relationships to disclose
Saori Goto
No relevant relationships to disclose
Atsushi Itami
No relevant relationships to disclose
Takeshi Kato
No relevant relationships to disclose